The Austrian Agency for Health and Food Safety has issued marketing authorization to pSivida ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME). The injectable, sustained-release ...
Tags: Marketing Authorization, reatment of vision impairment, clinical product